<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134603">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02044679</url>
  </required_header>
  <id_info>
    <org_study_id>NU365</org_study_id>
    <nct_id>NCT02044679</nct_id>
  </id_info>
  <brief_title>Evaluation of Spot Urine as a Biomarker of Fluid Intake in Real Life Conditions</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danone Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Danone Research</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate urine osmolality as a marker of fluid intake, in healthy subjects displaying a wide
      range of fluid intake behaviors
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>N/A</study_design>
  <primary_outcome>
    <measure>Osmolality</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Healthy Adults</condition>
  <arm_group>
    <arm_group_label>A = Increase water intake 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B = Increase water intake 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>C = no change</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Water</intervention_name>
    <arm_group_label>A = Increase water intake 1</arm_group_label>
    <arm_group_label>B = Increase water intake 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>C = no change</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy female and male subjects aged 20- 30 years old (both ages included).

          -  BMI within the range 20-25 kg/m2 (both inclusive).

          -  Height within the range 1.60-1.75 m (both inclusive) for female subjects and
             1.70-1.85 m (both inclusive) for male subjects.

          -  Monophasic contraceptive method (female subjects only)

          -  Smoking less than 10 cigarettes/day

          -  Fluid intake habits falling within one of three designated arms

        Exclusion Criteria:

          -  Pregnant woman (as determined by a pregnancy test) or woman planning to become
             pregnant during the study; breast-feeding woman.

          -  Any clinically relevant acute or chronic diseases which could interfere with the
             subjects' safety during the trial, or expose them to undue risk, or which could
             interfere with the study objectives.

          -  Having participated in a clinical study for the renal diseases or having received any
             treatment related to the kidneys, cardiovascular disease or to hypertension in the
             last 12 months.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christine M'RINI, MD, PhD</last_name>
    <phone>+33 1 69 35 70 00</phone>
  </overall_contact>
  <location>
    <facility>
      <name>BIOTRIAL</name>
      <address>
        <city>Rennes</city>
        <zip>35042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Béatrice Dr ASTRUC, MD</last_name>
      <phone>33 (0)2 99 59 91 91</phone>
      <email>BEATRICE.ASTRUC@BIOTRIAL.COM</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 22, 2014</lastchanged_date>
  <firstreceived_date>January 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
